Regeneron Pharmaceuticals, Inc.
CorpDigest
Regeneron Pharmaceuticals, Inc.
Annual Revenue
Last reviewed: 2025-07-15 · By Swet Parvadiya
FY2023 Revenue
$13.1B
Regeneron Pharmaceuticals, Inc. reported $13.1B in revenue for fiscal year 2023. In 2024, revenue increased to $14.2B.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.